A- A A+

For Patients & Visitors

Find a Doctor

Find a Doctor

Dr Tan Lip Kun

Photo of Dr Tan Lip Kun
MB ChB, MRCP, MRCPath (Haem), FRCPath
Senior Consultant, Haematology Division, Department of Laboratory Medicine, National University Hospital
Clinical Director, Department of Laboratory Medicine, National University Hospital
Senior Consultant, Department of Haematology-Oncology, National University Cancer Institute, Singapore

Medical Director, Blood Bank, National University Hospital

Medical Director, Collection Facility, Apheresis Unit @ NCIS, National University Cancer Institute, Singapore

Medical Director, Processing Facility, National University Hospital

Medical Director, Tissue Engineering & Cell Therapy Laboratory, National University Hospital

Cancer, Laboratory Medicine
Sub Specialty:
Haematology, Haematology-Oncology
Medical and Surgical Conditions:
Blood Cancer, Bone Marrow Transplant, Leukaemia, Lymphoma, Myelodysplastic Syndrome (MDS), Myeloproliferative Neoplasms (MPN), Stem Cell Transplant
Special Interest:

Haematopoietic stem cell transplantation
Blood transfusion medicine

National University Hospital
National University Cancer Institute, Singapore
National University Health System

Dr Tan Lip Kun graduated from Leicester Medical School, UK, in 1989. She obtained her MRCP in 1993 and completed her post-graduate training in Haematology in 1998 and obtained her MRCPath in 1998. She was conferred FRCPath in 2006. Dr Tan has experience in both laboratory and clinical haematology. Her main field of interests in Haematology is in Acute Leukaemias, Lymphoproliferative Diseases, Haematopoietic Stem Cell Transplantation and Transfusion Medicine. She is the Programme Director for NUHS Adult and Paediatric Haematopoeietic Stem Cell Transplant Clinical Programme, a FACT-accredited centre. Dr Tan is the Clinical Director of the Department of Laboratory Medicine.
She is also the Medical Director for the Stem Cell Processing Laboratory, Blood Transfusion Services and Blood Donation Centre which are accreditated with the College of American Pathologist (CAP) and American Association of Blood Banking (AABB). Dr Tan holds the Chairperson for the Hospital Blood Usage Committee and is one of the team member of the Quality Improvement and Risk Management (QIM) of the hospital. She is an appointed member of the Product Vigilance Advisory Committee of HSA. Dr Tan is an Assistant Professor with the Department of Pathology, Yong Loo Lin Medical School, NUS. She participates in both undergraduate and postgraduate teaching. She is a member of the Residency Advisory Committee for Haematology.

Research and Publications

​1. Sivakumaran M, Ghosh K, Munks R, Gelsthorpe K, Tan L, Wood J K. Delayed cutaneous reaction to unfractionated low molecular weight heparin and danaparoid..Br J Haematol 1994, Apr; 86 (4) : 893 – 4.

2. Sivakumaran M, Ghosh K, Tan L, Revill J, Hutchinson RM, Wood JK. Evaluation of the Pall RC100 leucocyte removal filters and the effect of air introduction on its performance. Haematologia (Budap). 1996;27(4):211-6.

3. Tan LK. Chloramphenicol-induced aplastic anaemia. Should its topical use be abandoned? SMJ, 40 (7) : PP 445-6, JUL 1999.

4. Tan LK, Suri R, Ong SK, Lim HL. Immunoglobulin D multiple myeloma in our hospital. SMJ, 41 (10) : 500-4, OCT 2000.

5. Tan LK. Severe haematological adverse reaction. Ticlopidine-induced aplastic anaemia, adverse drug reaction news. Published by the expert panel on adverse drug reactions and the national pharmaceutical administration, Ministry of Health, Nov 2001.

6. LeeKH, TanLK, PrabhakaranK, TanKC. Successful living-related liver transplantation from a donor with von Willebrand’s disease. Liver Transplant and Surgery, 5 (6), PP 532-33, NOV. 1999.

7. Chng WJ, Tan LK, Liu TC,. Cyclosporin therapy for patients with Chronic Renal Failure who developed Pure Red Cell Aplasia following Erythropoietin Therapy. American Journal of Kidney Disease. 2003 Mar;41(3):692-5.

8. Lau LG, Tan LK, Koay ES, Ee MH, Tan SH, Liu TC. Acute lymphoblastic leukemia with the phenotype of a putative B-cell/T-cell bipotential precursor. Am J Hematol. 2004 Oct;77(2):156.

9. Lau LG, Tan LK, Salto-Tellez M, Koay ES, Liu TC. T-cell post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: another case and a review of the literature. Bone Marrow Transplant. 2004 Sep 6 (e-pub).

10. Lau LG, Chng WJ, Liu TC, Tan LK, Ong KH, Mow MF, Kueh YK. Clinico-pathological Study of Myelodysplastic Syndromes in Asians at an institution. Ann Acad Med Singapore. 2004 Sep;33(5):589-95.

11. LauLG, TanLK, Koay E, Liu TC.Acute lymphoblastic leukaemia after tandem autologous stem cell transplantation for multiple myeloma. Leukemia. 2005 Feb;19(2):299-301.

12. Koh LP, Chen CS, Tai BC, Hwang WYK, Tan LK, et al. Impact of Post-grafting Immunosuppressive regimens on non-relapse mortality and survival after non-myeloablative allogeneic haematopoietic stem cell transplant using fludarabine and low dose total body irradiation 200cGy. In press. BBMT 2007.

13. Yeo WT, Tan LK, Dan YY, Wai CT. Delayed bleeding after liver biopsy: a dreaded complication. Singapore Med J. 2008 Jan;49(1):76-80.

14. Poon LM, Chia HY, Tan LK, Liu TC, Koh LP. Transpl Infect Dis. 2009. Apr;11(2):160-6. Epub 2009 Feb 18. Successful intensive chemotherapy followed by autologous hematopoietic cell transplantation in a patient with acute myeloid leukemia and hepatosplenic candidiasis: case report and review of literature.

15. Ng ES, Aw DC, Tan KB, Poon ML, Yap ES, Liu TC, Tan LK, Chng WJ, Koh LP. Leuk Res, 2010 May;34(5):e130-2. Epub 2009 Dec 21. Neutrophilic eccrine hidradenitis associated with decitabine.

16. Hereditary Thrombophilia in an unselected cohort of venous thrombosis patients in Snigapore. J Clin Pathol 2011, May 18 (e-pub) Lee LH, Liu TC, Kuperan P, Tan LK, Tan D, Poon ML, Ong KH, Fong SZ, Tan MY, Ng HJ.

17. Ministry of health clinical practice guidelines : clinical blood transfusion. Koh BC, Chong LL, Goh LG, Iau P, Kuperan P, Lee LH, Lim LC, Ng HJ, Sia A, Tan HH, Tan LK, Tay KH, Teo LT, Ting WC, Yong TT; Ministry of Health Clinical Practice Guidelines Workgroup on Clinical Blood Transfusion. Singapore Med J. 2011 Mar;52(3):209-18; quiz 219

18. A febrile donor. Tang JW. Ng Y. Koay ES, Leow GH, Yap ES, Chan D, Tan LK, Tambyah PA. Clin Chem 2010, Mar; 56.

19. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. Poon LM, Jin J, Chee YL, Ding Y, Lee YM, Chng WJ, Chai LY, Tan LK, Hsu LY.Singapore Med J. 2012 Nov;53(11):720-5.

20. Comparing peripheral blood stem cell collection using the COBE Spectra, Haemonetics MCS+ and Baxter Amicus. Wu FY, Heng KK, Salleh RB, Soh TG, Lee JJ, Mah J, Linn YC, Loh Y, Hwang W, Tan LK, Law P, Goh YT. Transfus Apher Sci. 2012 Dec;47(3):345-50.

21. World blood donor day: the challenges ahead. Tan LK. Ann Acad Med Singapore, Editorial Review. 2012 Jun;41(6):236-8.